Ewch i’r prif gynnwys
Canolfan Treialon Ymchwil

Studies and trials

Mae'r cynnwys hwn ar gael yn Saesneg yn unig.

DivisionChevron up
RecruitingChevron up
StatusChevron up
Filter resultsFilter

21 to 30 of 172 search results

STORM

The Standing up for Myself (STORM) psychosocial group intervention for young people and adults with intellectual disabilities - feasibility study.

OSCAR

Establishing the impact of COVID-19 on the health of domiciliary care workers in Wales: developing a model for UK service planning and carer support.

PEACH

Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients.

LEARN

Listening to the experience of participants in neurosurgical trials.

PHaCT

Preventing Homelessness, improving health for people leaving prison: a pilot randomised controlled trial of a Critical Time intervention.

EVITA

A randomised trial of aminophylline, magnesium sulfate or salbutamol intravenous therapy for acute severe asthma in children and young people.

CREAM

CREAM was a double blind, randomised controlled trial to assess whether children with eczema benefitted from antibiotic treatment and was based in general practices and dermatology clinics in Wales, Scotland, and the West of England.

AML17

Between 2009 and 2014 AML17 recruited over 3,500 patients aged generally under 60 to what is the largest ever trial in Acute Myeloid Leukaemia run in the UK.

AML18

AML18 is an international trial looking at treatment for acute myeloid leukaemia (AML) and high risk myelodysplastic syndrome (MDS) across approximately 90 centres in the UK and Denmark. It is designed mainly for people over 60 years of age who are fit enough to have intensive chemotherapy.

AML19

AML19 is the current trial for younger adults with acute myeloid leukaemia (AML) or high risk myelodysplastic syndrome (MDS).